News

New funding

New funding

Monday, March 27th 2017
Vaxinano has obtained funding from Bpifrance for the evaluation of 2 vaccine candidates
The French Public Investment Bank, Bpifrance, through its Feasibility of Innovation program, is funding two innovative Vaxinano projects for two vaccine candidates in the veterinary field. These will support the vaccine platform developed by Vaxinano.
< Back